Adults who were diagnosed with hypertension between ages 35 to 44 had smaller brain sizes and were more likely to be diagnosed with dementia compared to adults their age with normal blood pressure, according to a new study
High blood pressure in young adults is linked to smaller brain size and increased risk of dementia, a new study has found.
Adults who were diagnosed with hypertension between ages 35 to 44 had smaller brain sizes and were more likely to be diagnosed with dementia compared to adults their age with normal blood pressure, according to a study published Monday in Hypertension, a journal of the American Heart Association.Adults under age 35 had the largest reductions in brain volume compared to adults their age without high blood pressure, which could come with adverse health effects, said Dr.
Reducing other risk factors for dementia such as obesity, diabetes, high cholesterol and smoking also decreases your risk of developing dementia, Galvin said.This study reaffirms the importance of young people getting regular health check-ups and taking good care of their health in early years, Finney noted.If you notice changes in memory, thinking or behavior as you age, let a medical professional know, he added.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
We Are CNN | CNN Creative Marketing
Baca lebih lajut »
Mazda's new all-electric high-riding hatchback isn't very appealingMazda's new EV offers just 100 miles of all-electric range and has a downmarket interior.a
Baca lebih lajut »
Stocks fall as tech retreats; price of oil hits 7-year highTechnology companies led a broad slide for stocks on Wall Street Monday, as rising bond yields and energy prices stoked investors' concerns about higher inflation.
Baca lebih lajut »
Helen Skelton shows off bump in stunning figure-hugging dress with high slitHelen Skelton shows off bump in stunning figure-hugging dress with high slit
Baca lebih lajut »
India's Divi's Labs hits record high on Merck's positive trial data for COVID-19 drugShares of India's Divi's Laboratories Ltd , which makes the main ingredient of Merck & Co's experimental antiviral pill, soared 10% on Monday, after the pharmaceutical giant reported positive clinical trial results for the drug.
Baca lebih lajut »